HEADER PROTEIN TRANSPORT 07-JUL-03 1PY1 TITLE COMPLEX OF GGA1-VHS DOMAIN AND BETA-SECRETASE C-TERMINAL TITLE 2 PHOSPHOPEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA1; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: VHS DOMAIN (RESIDUES 2-157); COMPND 5 SYNONYM: GOLGI-LOCALIZED, GAMMA EAR-CONTAINING, ARF-BINDING PROTEIN COMPND 6 1, GAMMA-ADAPTIN RELATED PROTEIN 1; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: BETA-SECRETASE; COMPND 10 CHAIN: E, F, G, H; COMPND 11 FRAGMENT: C-TERMINUS (RESIDUES 494-501); COMPND 12 SYNONYM: BETA-SITE APP CLEAVING ENZYME, BETA-SITE AMYLOID PRECURSOR COMPND 13 PROTEIN CLEAVING ENZYME, ASPARTYL PROTEASE 2, ASP 2, ASP2, MEMBRANE- COMPND 14 ASSOCIATED ASPARTIC PROTEASE 2, MEMAPSIN-2; COMPND 15 EC: 3.4.23.-; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GGA1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX2T; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: YES KEYWDS VHS DOMAIN OF GGA1, BETA-SECRETASE, PROTEIN-PEPTIDE COMPLEX, SUPER KEYWDS 2 HELIX, PROTEIN TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR G.ZHU,X.C.ZHANG REVDAT 5 06-NOV-24 1PY1 1 REMARK REVDAT 4 16-AUG-23 1PY1 1 SEQADV LINK REVDAT 3 24-FEB-09 1PY1 1 VERSN REVDAT 2 13-JAN-04 1PY1 1 JRNL REVDAT 1 04-NOV-03 1PY1 0 JRNL AUTH X.HE,G.ZHU,G.KOELSCH,K.RODGERS,X.C.ZHANG,J.TANG JRNL TITL BIOCHEMICAL AND STRUCTURAL CHARACTERIZATION OF THE JRNL TITL 2 INTERACTION OF MEMAPSIN 2 (BETA-SECRETASE) CYTOSOLIC DOMAIN JRNL TITL 3 WITH THE VHS DOMAIN OF GGA PROTEINS. JRNL REF BIOCHEMISTRY V. 42 12174 2003 JRNL REFN ISSN 0006-2960 JRNL PMID 14567678 JRNL DOI 10.1021/BI035199H REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 22006 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.288 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.900 REMARK 3 FREE R VALUE TEST SET COUNT : 858 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.69 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1883 REMARK 3 BIN R VALUE (WORKING SET) : 0.3920 REMARK 3 BIN FREE R VALUE : 0.5110 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 67 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.062 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4739 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 37 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.50000 REMARK 3 B22 (A**2) : 15.37000 REMARK 3 B33 (A**2) : -19.87000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.51 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.53 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.980 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.560 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.730 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.090 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.320 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 25.69 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : SEP.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1PY1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JUL-03. REMARK 100 THE DEPOSITION ID IS D_1000019687. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-MAR-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC OPTICS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22025 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 25.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.37300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1JWG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, AMMONIUM SULFATE, REMARK 280 CACODYLATE, PH 6.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 35.07000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.71000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.07000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.71000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 SER A 1 REMARK 465 GLU A 2 REMARK 465 PRO A 3 REMARK 465 ALA A 4 REMARK 465 MET A 5 REMARK 465 GLU A 6 REMARK 465 PRO A 7 REMARK 465 LYS A 150 REMARK 465 LEU A 151 REMARK 465 PRO A 152 REMARK 465 ASP A 153 REMARK 465 ASP A 154 REMARK 465 THR A 155 REMARK 465 THR A 156 REMARK 465 PHE A 157 REMARK 465 GLY B 0 REMARK 465 SER B 1 REMARK 465 GLU B 2 REMARK 465 PRO B 3 REMARK 465 ALA B 4 REMARK 465 MET B 5 REMARK 465 GLU B 6 REMARK 465 LYS B 146 REMARK 465 SER B 147 REMARK 465 ASP B 148 REMARK 465 PRO B 149 REMARK 465 LYS B 150 REMARK 465 LEU B 151 REMARK 465 PRO B 152 REMARK 465 ASP B 153 REMARK 465 ASP B 154 REMARK 465 THR B 155 REMARK 465 THR B 156 REMARK 465 PHE B 157 REMARK 465 GLY C 0 REMARK 465 SER C 1 REMARK 465 GLU C 2 REMARK 465 PRO C 3 REMARK 465 ALA C 4 REMARK 465 MET C 5 REMARK 465 GLU C 6 REMARK 465 PRO C 7 REMARK 465 LYS C 146 REMARK 465 SER C 147 REMARK 465 ASP C 148 REMARK 465 PRO C 149 REMARK 465 LYS C 150 REMARK 465 LEU C 151 REMARK 465 PRO C 152 REMARK 465 ASP C 153 REMARK 465 ASP C 154 REMARK 465 THR C 155 REMARK 465 THR C 156 REMARK 465 PHE C 157 REMARK 465 GLY D 0 REMARK 465 SER D 1 REMARK 465 GLU D 2 REMARK 465 PRO D 3 REMARK 465 ALA D 4 REMARK 465 MET D 5 REMARK 465 GLU D 6 REMARK 465 PRO D 7 REMARK 465 LYS D 150 REMARK 465 LEU D 151 REMARK 465 PRO D 152 REMARK 465 ASP D 153 REMARK 465 ASP D 154 REMARK 465 THR D 155 REMARK 465 THR D 156 REMARK 465 PHE D 157 REMARK 465 ALA E 1 REMARK 465 ALA F 1 REMARK 465 ALA G 1 REMARK 465 ASP G 2 REMARK 465 ALA H 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O1P SEP G 5 O1P SEP G 5 2565 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 101 -6.27 -59.14 REMARK 500 TYR A 102 -142.17 -139.92 REMARK 500 ASN B 38 14.48 -66.66 REMARK 500 ASP B 40 127.35 -173.14 REMARK 500 SER B 76 64.23 -118.63 REMARK 500 TYR B 102 -96.83 -127.21 REMARK 500 LEU B 126 56.23 -142.25 REMARK 500 GLU B 129 85.38 -60.54 REMARK 500 ASN C 22 127.69 -35.28 REMARK 500 ASP C 26 72.95 -111.97 REMARK 500 GLU C 39 -90.69 -80.14 REMARK 500 ARG C 80 -80.15 -46.94 REMARK 500 TYR C 102 -113.95 -120.50 REMARK 500 GLU C 129 85.59 -69.44 REMARK 500 ASN D 22 124.72 -39.49 REMARK 500 GLU D 39 -73.41 -42.21 REMARK 500 ARG D 80 -75.53 -54.02 REMARK 500 LYS D 101 -4.23 -57.21 REMARK 500 TYR D 102 -116.93 -138.63 REMARK 500 LEU G 7 -172.07 -60.36 REMARK 500 REMARK 500 REMARK: NULL DBREF 1PY1 A 1 157 UNP Q9UJY5 GGA1_HUMAN 2 157 DBREF 1PY1 B 1 157 UNP Q9UJY5 GGA1_HUMAN 2 157 DBREF 1PY1 C 1 157 UNP Q9UJY5 GGA1_HUMAN 2 157 DBREF 1PY1 D 1 157 UNP Q9UJY5 GGA1_HUMAN 2 157 DBREF 1PY1 E 1 8 UNP P56817 BACE1_HUMAN 494 501 DBREF 1PY1 F 1 8 UNP P56817 BACE1_HUMAN 494 501 DBREF 1PY1 G 1 8 UNP P56817 BACE1_HUMAN 494 501 DBREF 1PY1 H 1 8 UNP P56817 BACE1_HUMAN 494 501 SEQADV 1PY1 GLY A 0 UNP Q9UJY5 CLONING ARTIFACT SEQADV 1PY1 SER A 1 UNP Q9UJY5 MET 1 CLONING ARTIFACT SEQADV 1PY1 GLY B 0 UNP Q9UJY5 CLONING ARTIFACT SEQADV 1PY1 SER B 1 UNP Q9UJY5 MET 1 CLONING ARTIFACT SEQADV 1PY1 GLY C 0 UNP Q9UJY5 CLONING ARTIFACT SEQADV 1PY1 SER C 1 UNP Q9UJY5 MET 1 CLONING ARTIFACT SEQADV 1PY1 GLY D 0 UNP Q9UJY5 CLONING ARTIFACT SEQADV 1PY1 SER D 1 UNP Q9UJY5 MET 1 CLONING ARTIFACT SEQADV 1PY1 SEP E 5 UNP P56817 SER 498 MODIFIED RESIDUE SEQADV 1PY1 SEP F 5 UNP P56817 SER 498 MODIFIED RESIDUE SEQADV 1PY1 SEP G 5 UNP P56817 SER 498 MODIFIED RESIDUE SEQADV 1PY1 SEP H 5 UNP P56817 SER 498 MODIFIED RESIDUE SEQRES 1 A 158 GLY SER GLU PRO ALA MET GLU PRO GLU THR LEU GLU ALA SEQRES 2 A 158 ARG ILE ASN ARG ALA THR ASN PRO LEU ASN LYS GLU LEU SEQRES 3 A 158 ASP TRP ALA SER ILE ASN GLY PHE CYS GLU GLN LEU ASN SEQRES 4 A 158 GLU ASP PHE GLU GLY PRO PRO LEU ALA THR ARG LEU LEU SEQRES 5 A 158 ALA HIS LYS ILE GLN SER PRO GLN GLU TRP GLU ALA ILE SEQRES 6 A 158 GLN ALA LEU THR VAL LEU GLU THR CYS MET LYS SER CYS SEQRES 7 A 158 GLY LYS ARG PHE HIS ASP GLU VAL GLY LYS PHE ARG PHE SEQRES 8 A 158 LEU ASN GLU LEU ILE LYS VAL VAL SER PRO LYS TYR LEU SEQRES 9 A 158 GLY SER ARG THR SER GLU LYS VAL LYS ASN LYS ILE LEU SEQRES 10 A 158 GLU LEU LEU TYR SER TRP THR VAL GLY LEU PRO GLU GLU SEQRES 11 A 158 VAL LYS ILE ALA GLU ALA TYR GLN MET LEU LYS LYS GLN SEQRES 12 A 158 GLY ILE VAL LYS SER ASP PRO LYS LEU PRO ASP ASP THR SEQRES 13 A 158 THR PHE SEQRES 1 B 158 GLY SER GLU PRO ALA MET GLU PRO GLU THR LEU GLU ALA SEQRES 2 B 158 ARG ILE ASN ARG ALA THR ASN PRO LEU ASN LYS GLU LEU SEQRES 3 B 158 ASP TRP ALA SER ILE ASN GLY PHE CYS GLU GLN LEU ASN SEQRES 4 B 158 GLU ASP PHE GLU GLY PRO PRO LEU ALA THR ARG LEU LEU SEQRES 5 B 158 ALA HIS LYS ILE GLN SER PRO GLN GLU TRP GLU ALA ILE SEQRES 6 B 158 GLN ALA LEU THR VAL LEU GLU THR CYS MET LYS SER CYS SEQRES 7 B 158 GLY LYS ARG PHE HIS ASP GLU VAL GLY LYS PHE ARG PHE SEQRES 8 B 158 LEU ASN GLU LEU ILE LYS VAL VAL SER PRO LYS TYR LEU SEQRES 9 B 158 GLY SER ARG THR SER GLU LYS VAL LYS ASN LYS ILE LEU SEQRES 10 B 158 GLU LEU LEU TYR SER TRP THR VAL GLY LEU PRO GLU GLU SEQRES 11 B 158 VAL LYS ILE ALA GLU ALA TYR GLN MET LEU LYS LYS GLN SEQRES 12 B 158 GLY ILE VAL LYS SER ASP PRO LYS LEU PRO ASP ASP THR SEQRES 13 B 158 THR PHE SEQRES 1 C 158 GLY SER GLU PRO ALA MET GLU PRO GLU THR LEU GLU ALA SEQRES 2 C 158 ARG ILE ASN ARG ALA THR ASN PRO LEU ASN LYS GLU LEU SEQRES 3 C 158 ASP TRP ALA SER ILE ASN GLY PHE CYS GLU GLN LEU ASN SEQRES 4 C 158 GLU ASP PHE GLU GLY PRO PRO LEU ALA THR ARG LEU LEU SEQRES 5 C 158 ALA HIS LYS ILE GLN SER PRO GLN GLU TRP GLU ALA ILE SEQRES 6 C 158 GLN ALA LEU THR VAL LEU GLU THR CYS MET LYS SER CYS SEQRES 7 C 158 GLY LYS ARG PHE HIS ASP GLU VAL GLY LYS PHE ARG PHE SEQRES 8 C 158 LEU ASN GLU LEU ILE LYS VAL VAL SER PRO LYS TYR LEU SEQRES 9 C 158 GLY SER ARG THR SER GLU LYS VAL LYS ASN LYS ILE LEU SEQRES 10 C 158 GLU LEU LEU TYR SER TRP THR VAL GLY LEU PRO GLU GLU SEQRES 11 C 158 VAL LYS ILE ALA GLU ALA TYR GLN MET LEU LYS LYS GLN SEQRES 12 C 158 GLY ILE VAL LYS SER ASP PRO LYS LEU PRO ASP ASP THR SEQRES 13 C 158 THR PHE SEQRES 1 D 158 GLY SER GLU PRO ALA MET GLU PRO GLU THR LEU GLU ALA SEQRES 2 D 158 ARG ILE ASN ARG ALA THR ASN PRO LEU ASN LYS GLU LEU SEQRES 3 D 158 ASP TRP ALA SER ILE ASN GLY PHE CYS GLU GLN LEU ASN SEQRES 4 D 158 GLU ASP PHE GLU GLY PRO PRO LEU ALA THR ARG LEU LEU SEQRES 5 D 158 ALA HIS LYS ILE GLN SER PRO GLN GLU TRP GLU ALA ILE SEQRES 6 D 158 GLN ALA LEU THR VAL LEU GLU THR CYS MET LYS SER CYS SEQRES 7 D 158 GLY LYS ARG PHE HIS ASP GLU VAL GLY LYS PHE ARG PHE SEQRES 8 D 158 LEU ASN GLU LEU ILE LYS VAL VAL SER PRO LYS TYR LEU SEQRES 9 D 158 GLY SER ARG THR SER GLU LYS VAL LYS ASN LYS ILE LEU SEQRES 10 D 158 GLU LEU LEU TYR SER TRP THR VAL GLY LEU PRO GLU GLU SEQRES 11 D 158 VAL LYS ILE ALA GLU ALA TYR GLN MET LEU LYS LYS GLN SEQRES 12 D 158 GLY ILE VAL LYS SER ASP PRO LYS LEU PRO ASP ASP THR SEQRES 13 D 158 THR PHE SEQRES 1 E 8 ALA ASP ASP ILE SEP LEU LEU LYS SEQRES 1 F 8 ALA ASP ASP ILE SEP LEU LEU LYS SEQRES 1 G 8 ALA ASP ASP ILE SEP LEU LEU LYS SEQRES 1 H 8 ALA ASP ASP ILE SEP LEU LEU LYS MODRES 1PY1 SEP E 5 SER PHOSPHOSERINE MODRES 1PY1 SEP F 5 SER PHOSPHOSERINE MODRES 1PY1 SEP G 5 SER PHOSPHOSERINE MODRES 1PY1 SEP H 5 SER PHOSPHOSERINE HET SEP E 5 10 HET SEP F 5 10 HET SEP G 5 10 HET SEP H 5 10 HETNAM SEP PHOSPHOSERINE HETSYN SEP PHOSPHONOSERINE FORMUL 5 SEP 4(C3 H8 N O6 P) FORMUL 9 HOH *37(H2 O) HELIX 1 1 THR A 9 THR A 18 1 10 HELIX 2 2 ASP A 26 LEU A 37 1 12 HELIX 3 3 GLU A 42 GLN A 56 1 15 HELIX 4 4 GLN A 59 CYS A 77 1 19 HELIX 5 5 GLY A 78 GLY A 86 1 9 HELIX 6 6 LYS A 87 SER A 99 1 13 HELIX 7 7 TYR A 102 THR A 107 5 6 HELIX 8 8 SER A 108 LEU A 126 1 19 HELIX 9 9 GLU A 129 GLN A 142 1 14 HELIX 10 10 THR B 9 THR B 18 1 10 HELIX 11 11 ASP B 26 ASN B 38 1 13 HELIX 12 12 GLU B 42 GLN B 56 1 15 HELIX 13 13 GLN B 59 SER B 76 1 18 HELIX 14 14 GLY B 78 LYS B 87 1 10 HELIX 15 15 LYS B 87 SER B 99 1 13 HELIX 16 16 LEU B 103 THR B 107 5 5 HELIX 17 17 SER B 108 LEU B 126 1 19 HELIX 18 18 GLU B 129 GLN B 142 1 14 HELIX 19 19 THR C 9 THR C 18 1 10 HELIX 20 20 ASP C 26 ASN C 38 1 13 HELIX 21 21 GLU C 42 GLN C 56 1 15 HELIX 22 22 GLN C 59 SER C 76 1 18 HELIX 23 23 GLY C 78 GLY C 86 1 9 HELIX 24 24 LYS C 87 SER C 99 1 13 HELIX 25 25 LEU C 103 THR C 107 5 5 HELIX 26 26 SER C 108 LEU C 126 1 19 HELIX 27 27 GLU C 129 GLN C 142 1 14 HELIX 28 28 THR D 9 THR D 18 1 10 HELIX 29 29 ASP D 26 ASN D 38 1 13 HELIX 30 30 GLU D 42 GLN D 56 1 15 HELIX 31 31 GLN D 59 CYS D 77 1 19 HELIX 32 32 GLY D 78 GLY D 86 1 9 HELIX 33 33 LYS D 87 SER D 99 1 13 HELIX 34 34 LEU D 103 THR D 107 5 5 HELIX 35 35 SER D 108 LEU D 126 1 19 HELIX 36 36 GLU D 129 GLN D 142 1 14 SSBOND 1 CYS A 34 CYS A 73 1555 1555 2.04 SSBOND 2 CYS B 34 CYS B 73 1555 1555 2.02 SSBOND 3 CYS C 34 CYS C 73 1555 1555 2.02 SSBOND 4 CYS D 34 CYS D 73 1555 1555 2.04 LINK C ILE E 4 N SEP E 5 1555 1555 1.33 LINK C SEP E 5 N LEU E 6 1555 1555 1.33 LINK C ILE F 4 N SEP F 5 1555 1555 1.33 LINK C SEP F 5 N LEU F 6 1555 1555 1.33 LINK C ILE G 4 N SEP G 5 1555 1555 1.33 LINK C SEP G 5 N LEU G 6 1555 1555 1.33 LINK C ILE H 4 N SEP H 5 1555 1555 1.33 LINK C SEP H 5 N LEU H 6 1555 1555 1.33 CRYST1 70.140 95.420 107.970 90.00 90.00 90.00 P 21 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014257 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010480 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009262 0.00000